Does Combination Therapy With Vancomycin and Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity Versus Vancomycin Alone in Pediatric Patients?

OBJECTIVES: To determine if the incidence of nephrotoxicity is higher in pediatric patients treated with the combination of vancomycin and piperacillin-tazobactam, compared to patients treated with vancomycin alone. Secondary objectives were to determine if admission to an intensive care unit (ICU),...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pediatr Pharmacol Ther
Asıl Yazarlar: McQueen, Katherine E., Clark, Dana W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Pediatric Pharmacy Advocacy Group 2016
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040177/
https://ncbi.nlm.nih.gov/pubmed/27713673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-21.4.332
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller